Pages that link to "Q24646520"
Jump to navigation
Jump to search
The following pages link to PAX3-FOXO1 fusion gene in rhabdomyosarcoma (Q24646520):
Displaying 50 items.
- Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer (Q26747750) (← links)
- The Tumorigenic Roles of the Cellular REDOX Regulatory Systems (Q26774894) (← links)
- The cell survival pathways of the primordial RNA-DNA complex remain conserved in the extant genomes and may function as proto-oncogenes (Q28649653) (← links)
- Chimeric RNAs in cancer and normal physiology (Q30252192) (← links)
- Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting (Q30426842) (← links)
- Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells (Q33615694) (← links)
- Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association (Q33671944) (← links)
- An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report (Q33830449) (← links)
- Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells (Q34245749) (← links)
- Childhood and adolescent cancer statistics, 2014. (Q34401667) (← links)
- Cyclin-dependent kinase 4 phosphorylates and positively regulates PAX3-FOXO1 in human alveolar rhabdomyosarcoma cells (Q34612870) (← links)
- Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state (Q35022234) (← links)
- Clonality and evolutionary history of rhabdomyosarcoma (Q35175269) (← links)
- The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway (Q35586103) (← links)
- Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors (Q35711420) (← links)
- Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options (Q35818209) (← links)
- AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell (Q35881962) (← links)
- Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation (Q35987311) (← links)
- Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion (Q37150545) (← links)
- PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis (Q37337884) (← links)
- Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcoma (Q37381276) (← links)
- PAX3-FKHR regulates the expression of pleiotrophin to mediate motility in alveolar rhabdomyosarcoma cells (Q37384314) (← links)
- Molecular and cellular biology of rhabdomyosarcoma. (Q37630588) (← links)
- A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. (Q38083828) (← links)
- Heparanase-1 and components of the hedgehog signalling pathway are increased in untreated alveolar orbital rhabdomyosarcoma (Q38396012) (← links)
- Rhabdomyosarcoma in adults: new perspectives on therapy (Q38480485) (← links)
- Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma (Q38489532) (← links)
- FOXO transcription factors in cancer development and therapy (Q38674456) (← links)
- JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. (Q38688601) (← links)
- P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma. (Q38740103) (← links)
- Involvement of Numb-mediated HIF-1α inhibition in anti-proliferative effect of PNA-antimiR-182 in trastuzumab-sensitive and -resistant SKBR3 cells (Q38819850) (← links)
- The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma (Q38829089) (← links)
- JAZF1 promotes proliferation of C2C12 cells, but retards their myogenic differentiation through transcriptional repression of MEF2C and MRF4-Implications for the role of Jazf1 variants in oncogenesis and type 2 diabetes (Q38860982) (← links)
- DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation. (Q39266150) (← links)
- Connections between Transcription Downstream of Genes and cis-SAGe Chimeric RNA. (Q45073669) (← links)
- Neuroblastoma pathogenesis: deregulation of embryonic neural crest development (Q45875651) (← links)
- Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma (Q50421625) (← links)
- New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling (Q50804445) (← links)
- PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. (Q51033392) (← links)
- PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis. (Q54975630) (← links)
- Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas (Q55396560) (← links)
- Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma (Q58109286) (← links)
- Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma (Q64376665) (← links)
- Trans-spliced long non-coding RNA: an emerging regulator of pluripotency. (Q64941702) (← links)
- Chimeric RNA in Cancer and Stem Cell Differentiation (Q90230311) (← links)
- Gene fusions and chimeric RNAs, and their implications in cancer (Q91940305) (← links)
- A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries (Q92637772) (← links)
- c-MET expression potentially contributes to the poor prognosis of rhabdomyosarcoma (Q92715474) (← links)
- Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers (Q93078947) (← links)
- Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells (Q96134571) (← links)